Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.250
-0.080 (-6.02%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $53.14 million as of April 28, 2025. Its market cap has decreased by -68.03% in one year.
Market Cap
53.14M
Enterprise Value
-97.72M
1-Year Change
-68.03%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $53.14M, a decrease of -94.38%. That is a compound annual growth rate of -44.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 53.14M | -4.58% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |